1. A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer

   • Caroline Hamm
   • Bre-Anne Fifield
   • Lisa A. Porter

   Original Paper 01 February 2022 Article: 49

   

2. RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression

   • Yin-Ling Zhang
   • Jin-Ling Cao
   • Da-Qiang Li

   Original Paper Open access 01 February 2022 Article: 48

   

3. Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer

   • Chinmoy K. Bose

   Review Article 29 January 2022 Article: 47

   

4. Combination of dasatinib and okadaic acid induces apoptosis and cell cycle arrest by targeting protein phosphatase PP2A in chronic myeloid leukemia cells

   • Buket Ozel
   • Sezgi Kipcak
   • Nur Selvi Gunel

   Original Paper 29 January 2022 Article: 46

   

5. ErbB2 promotes breast cancer metastatic potential via HSF1/LDHA axis-mediated glycolysis

   • Li He
   • Sinan Lv
   • Yuhua Zhao

   Original Paper 29 January 2022 Article: 45

   

6. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma

   • Wanjun Chen
   • Weijie Liang
   • Huayou Zhou

   Original Paper 29 January 2022 Article: 44

   

7. A 12-chemokine gene signature is associated with the enhanced immunogram scores and is relevant for precision immunotherapy

   • Xingchen Li
   • Zhiyi Wan
   • Lin Yang

   Original Paper 29 January 2022 Article: 43

   

8. The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma

   • Bakiye Goker Bagca
   • Cigir Biray Avci
   • Halil Bulent Karci

   Original Paper 29 January 2022 Article: 42

   

9. The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma

   • Jianpeng Li
   • Jinlong Cao
   • Junqiang Tian

   Original Paper 29 January 2022 Article: 41

   

10. A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways

    • Marzieh Shirin
    • Sajedeh Madadi
    • Ehsan Nazemalhosseini-Mojarad

    Original Paper 29 January 2022 Article: 40

    

11. CDK9 inhibitors in multiple myeloma: a review of progress and perspectives

    • Jędrzej Borowczak
    • Krzysztof Szczerbowski
    • Łukasz Szylberg

    Review Article Open access 29 January 2022 Article: 39

    

12. Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells

    • Lemeng Zhang
    • Tianli Cheng
    • Yongzhong Luo

    Original Paper Open access 29 January 2022 Article: 38